Mank, Austria

Günter Waxenecker

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010-2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gunter Waxenecker: Innovator in Monoclonal Antibody Development

Introduction

Gunter Waxenecker is a notable inventor based in Mank, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Gunter Waxenecker holds a patent for an invention titled "N-glycosylated antibody." This invention relates to a monoclonal antibody, or a fragment of the antibody, derived from a parental monoclonal antibody that recognizes the Lewis Y antigen. The invention is characterized by the Fc region of the antibody, or fragment, carrying a bi-sected hybrid type N-glycosylation pattern. Notably, this antibody demonstrates at least a tenfold increase in antibody-dependent cellular cytotoxicity (ADCC) and at least a 10% reduction in complement-dependent cytotoxicity (CDC) activity. This patent highlights his innovative approach to enhancing the efficacy of therapeutic antibodies.

Career Highlights

Throughout his career, Gunter has worked with several prominent companies in the biotechnology sector. He has been associated with Greenovation Biotech GmbH and Meridian Biopharmaceuticals GmbH, where he has contributed to various research and development projects. His work in these organizations has further solidified his reputation as a leading inventor in the field.

Collaborations

Gunter has collaborated with notable professionals in the industry, including Manfred Schuster and Gottfried Himmler. These collaborations have allowed him to expand his knowledge and expertise, leading to innovative breakthroughs in monoclonal antibody research.

Conclusion

Gunter Waxenecker's contributions to the field of biotechnology, particularly through his patent for N-glycosylated antibodies, demonstrate his commitment to advancing medical science. His collaborations and career highlights reflect his significant impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…